共 198 条
[1]
Giles J(2010)Management of rheumatoid arthritis: synovitis Rheumatology 1 955-963
[2]
Bathon JM(2008)Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomized, double-blind, parallel treatment trial Lancet 372 375-382
[3]
Emery P(2006)Evidence for differential acquired drug resistance to anti-tumor necrosis factor agents in rheumatoid arthritis Ann Rheum Dis 65 746-752
[4]
Breedveld FC(2009)Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis Arthritis Rheum 61 560-568
[5]
Hall S(2010)Sequential use of biologic therapy in rheumatoid arthritis Curr Opin Rheumatol 22 321-329
[6]
Durez P(2016)Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry and Joel M. Kremer 5,6 Arthritis Res Ther 18 280-549
[7]
Chang DJ(2017)Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials Rheumatology 56 541-3964
[8]
Robertson D(2008)Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease Blood 112 3959-997
[9]
Singh A(2008)Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double blind, placebo-controlled, randomized trial Lancet 371 987-1167
[10]
Pedersen RD(2007)Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor—evidence of clinical and radiographic benefit from an X-ray reader-blinded randomized controlled trial of tocilizumab Ann Rheum Dis 6 1162-1584